Unique randomized withdrawal heart failure trial with SGLT2 inhibitor
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- ESC Congress 2023International survey of secondary prevention of CHD
John W. McEvoy, MD, PhD
Joris Holtrop, MD
Ruxandra Maria Christodorescu, MD
Nadia Bonekamp, MD
- ESC Congress 2023Effect of SGLT2i on diuretic efficacy in acute heart failure
- ESC Congress 2023What is the best antithrombotic treatment post-PCI?
Marco Valgimigli, MD, PhD